Why Is Carnival Stock Surging on Tuesday?
Carnival Corporation Ltd. (NYSE: CCL ) stock is surging on Tuesday, primarily driven by ebbing crude oil prices and a broader market sector rally for airline and travel stocks. The Nasdaq is up 0.26% while the S&P 500 is flat and Consumer Discretionary is leading with a 0.60% gain. Oil prices fell for a fifth straight session, with Brent futures near $99 a barrel and crude oil futures around $91 as traders monitored diplomatic efforts regarding the conflict with Iran, coinciding with a U.S. President Donald Trump ‘s address to the UN General Assembly, according to Trading economics. Read Also: Bitcoin Just Hit a Seven-Month High. The Analyst Calling the Bottom Expects a Pullback Upcoming Third-Quarter Earnings Carnival Corporation will release third-quarter earnings before the opening bell on Sept. 29. Analysts expect the Miami, Florida-based firm to report quarterly earnings of $1.35 per stock, down from $1.43 per stock last year, on estimated quarterly revenue of $8.4 billion versus $8.15 billion previously. On June 23, the company reported mixed second-quarter results and issued third-quarter adjusted EPS guidance below estimates. Analyst Ratings Updates According to analyst tra
Carnival Corporation Ltd. (NYSE: CCL ) stock is surging on Tuesday, primarily driven by ebbing crude oil prices and a broader market sector rally for airline and travel stocks. 60% gain. S.
President Donald Trump ‘s address to the UN General Assembly, according to Trading economics. Read Also: Bitcoin Just Hit a Seven-Month High. The Analyst Calling the Bottom Expects a Pullback Upcoming Third-Quarter Earnings Carnival Corporation will release third-quarter earnings before the opening bell on Sept. 29.
15 billion previously. On June 23, the company reported mixed second-quarter results and issued third-quarter adjusted EPS guidance below estimates. Analyst Ratings Updates According to analyst tracking data, Goldman Sachs analyst Lizzie Dove maintained a Buy rating on Sept. 17, cutting the price forecast from $35 to $30.
Stifel analyst Steven Wieczynski maintained a Buy rating on Sept. 16, lowering the price forecast from $37 to $35. 6% below its 50-day SMA, which keeps the intermediate trend pointed down. 7% below its 200-day SMA and a death cross in March (50-day SMA below the 200-day SMA) still acting as an overhead drag.
90% over the past 90 days, so today’s strength reads like a bounce rather than a clean trend reversal. If the sector can keep holding near the top of the leaderboard, it increases the odds CCL’s rally attempt can build beyond a one-day pop. 93 at the time of publication on Tuesday, according to Pro data. Read Also: Trump's Drug Price Achievements Questioned Following Separate Most Favored Nation Contract Disclosures with Lilly, Pfizer Image via Shutterstock